- Home
- NLOP vs ORMP Comparison
NLOP vs ORMP Comparison
Compare NLOP & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NLOP | ORMP |
|---|---|---|
| Founded | N/A | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.9M | 170.3M |
| IPO Year | 2022 | 2010 |
Fundamental Metrics
Financial Performance| Metric | NLOP | ORMP |
|---|---|---|
| Price | $10.49 | $4.70 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 105.3K | ★ 199.5K |
| Earning Date | 05-19-2026 | 05-14-2026 |
| Dividend Yield | ★ 52.20% | 6.51% |
| EPS Growth | N/A | ★ 412.50 |
| EPS | 1.27 | ★ 2.76 |
| Revenue | ★ $118,915,000.00 | $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $8.24 | ★ $1.71 |
| Revenue Growth | N/A | ★ 49.25 |
| 52 Week Low | $10.36 | $2.09 |
| 52 Week High | $30.26 | $5.47 |
Technical Indicators
Market Signals| Indicator | NLOP | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 27.66 | 50.12 |
| Support Level | N/A | $3.91 |
| Resistance Level | $11.65 | $5.10 |
| Average True Range (ATR) | 0.26 | 0.18 |
| MACD | -0.06 | -0.05 |
| Stochastic Oscillator | 13.89 | 29.51 |
Price Performance
Historical ComparisonAbout NLOP Net Lease Office Properties of Beneficial Interest
Net Lease Office Properties is a Maryland real estate investment trust that, together with its consolidated subsidiaries, owns, operates, and finances a diversified portfolio of office properties mainly leased to corporate tenants on a single-tenant, net-lease basis. The company operates as a single operating and reportable segment focused on owning and managing office properties that generate revenue mainly from long-term lease agreements with tenants.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.